Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
DMG: From SWI/SNF’s role in cholesterol biosynthesis to new therapeutic opportunities |
Board of Trustees of the Leland Stanford Junior University / Capucine Van Rechem, PhD |
Innovation Grants |
2024 |
California |
Single Cell Analysis of Leukemia Initiation |
Stanford University / Michael Cleary, MD |
Innovation Grants |
2015 |
California |
Blockade of Mycn in neuroblastoma
|
University of California San Francisco / William Weiss |
Innovation Grants |
2008 |
California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Saving Lives, Saving Neurons, the Head Start Consortium for Young Children with Malignant Central Nervous System Tumors
|
Children’s Hospital Los Angeles / Jonathan Finlay, MD |
Phase I/II Infrastructure Grants |
2007 |
California |
Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).
|
University of California San Francisco / Michelle Hermiston, MD, PhD |
Young Investigator Grants |
2009 |
California |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD |
Innovation Grants |
2015 |
California |
Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors |
University of California, Davis / Wolf-Dietrich Heyer, PhD |
Innovation Grants |
2018 |
California |